This study of EZPAKTM Nutraceuticals was designed as a random selection of 250 patients from a pool of 1400 (200 given EZPAKTM and 50 control). The patients had a medical history taken and a physical examination preformed that included serum levels to serve as a base line. Following the data pooling an additional statistician evaluated and correlated the results. The construction of the study was to measure the capability of EZPAKTM Nutraceuticals to increase the serum levels in the study group at the end of three months.
This study consisted of an initial serum draw and subsequent draws at 1 month, 2 months and 3 months. Vitamins tested included A, E, B1, B2, B6, B12, C, D. Minerals were Calcium and Iron. IGF1 and FT3 were included to assess any increase in growth hormone and thyroid function.
Method of Study
In the first phase, each of the patients was randomly assigned to the study after appropriate approval was granted. A complete medical and surgical history was obtained at the time of the study and all of the necessary supporting laboratory data was obtained to assess the current serum levels.
Analysis of Data
The patient population ranged in age from 26 to 75 with a mean age of 49.7years. The average of the females was 48.8 years while the males were 51.2 years. There were 117 females in the study as compared to 132 males.